REMINDER: Our user survey closes TODAY, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,370.00
Bid: 12,370.00
Ask: 12,374.00
Change: 38.00 (0.31%)
Spread: 4.00 (0.032%)
Open: 12,350.00
High: 12,432.00
Low: 12,314.00
Prev. Close: 12,332.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Tropical Malaysia works to boost cold-storage, get more COVID-19 shots

Wed, 23rd Dec 2020 07:47

* Delivery map for vaccines needing ultra-cold storage

* Final talks with Russian and Chinese vaccine makers

* Aims to double AstraZeneca vaccines, buy more from Pfizer

* In talks with Moderna Inc, Johnson & Johnson
(Recasts, adds details on vaccine logistics)

By Liz Lee

KUALA LUMPUR, Dec 23 (Reuters) - Malaysia said on Wednesday
it was talking with Pfizer and other companies to secure
more COVID-19 vaccine doses to cover 83% of its population, and
is drawing up plans to arrange ultra-cold storage in its
tropical heat.

The Southeast Asian nation says it has so far got enough
doses to inoculate 40% of its 32 million people, and has
promised to spend $500 million to buy enough vaccines.

The government, which has struck a deal to buy 12.8 million
doses of U.S. drugmaker Pfizer-BioNTech's shot, said it was in
talks for an option to buy more doses to cover another fifth of
the population.

It is also in final talks to secure a total of 23.9 million
doses from Chinese manufacturers Sinovac Biotech Ltd and
CanSino Biologics, and from Russia's Gamaleya Institute, the
maker of the Sputnik V vaccine, Science Minister Khairy
Jamaluddin said.

It will secure additional AstraZeneca vaccines under
the global COVAX facility, and has begun talks with Moderna
and Johnson & Johnson as a buffer, the minister
added.

Malaysia, where temperatures average 30 degrees Celsius
year-round, wants to ensure a distribution network that does not
need to store vaccines for long, Khairy said.

"Once the Pfizer vaccines come in, we are hoping that it
will be a just-in-time roll out of vaccination," he said.

Pfizer's vaccines need to be stored and transported at minus
70 degrees Celsius (-94F), although they can be kept in a fridge
for up to five days, or up to 15 days in a thermal shipping box.

Some Asian countries have expressed reservations about the
Pfizer vaccine due to tropical heat, remote island communities
and a lack of ultra-cold freezers.

Malaysian's vaccine supply committee will identify
ultra-cold storage facilities and aims to stagger distribution
to ensure coverage in remote regions, ahead of the arrival of
Pfizer's first shipment in February, Khairy said.

Neighbouring Singapore was the first Asian nation to take
delivery of a batch of the Pfizer vaccine on Monday from
Belgium.

(Writing by Rozanna Latiff; Editing by Himani Sarkar, Michael
Perry abd Andrew Heavens)

More News
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.